Showing results 1 to 8 of 8
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
1979 | 89 | |||
2019 | 10 | |||
First results with RNA interference (RNAi) in chronic hepatitis b (CHB) using ARO-HBV Proceeding/Conference:Hepatology | 2018 | 56 | ||
Preliminary safety and antiviral activity of VIR-2218, an X-targeting HBV RNAi therapeutic, in chronic hepatitis B patients Proceeding/Conference:Journal of Hepatology | 2020 | 68 | ||
RO7062931 antisense oligonucleotide phase 1 study demonstrates target engagement in patients with chronic hepatitis B on established nucleos(t)ide therapy Proceeding/Conference:Journal of Hepatology | 2020 | 14 | ||
Short term RNA interference therapy in chronic hepatitis B using JNJ-3989 brings majority of patients to HBsAg < 100 IU/ml threshold Proceeding/Conference:Journal of Hepatology | 2019 | 48 | ||
2020 | 34 | |||
Tissue distribution of orally administered bismuth in the rat Journal:Clinical and Experimental Pharmacology and Physiology | 1980 | 60 |